Extravascular ICD Pivotal Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 393 participants.

Also called NCT04060680

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 393 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04060680
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Austria, Canada, Denmark, France, Hong Kong SAR China, Hungary, Italy, Netherlands, New Zealand, Norway, Poland, Saudi Arabia, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04060680. Non-randomized; no masking; primary purpose other. Start 2019-09-16 (actual); primary completion 2022-04-28 (actual). Results posted on 2023-07-03.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Extravascular ICD Pivotal Study
Acronym
EV ICD
Condition
Tachycardia
Condition
Ventricular Arrythmia
Intervention (Device)
Defibrillation using the Extravascular ICD
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct04060680
Content hash
eaafd5213ab6c99f4b41a74d07ac75c5285bbc854c4782e3bca868360a43599e